Find company research, competitor information, contact details & financial data for SUN PHARMA GLOBAL (FZE). Get the latest business insights from D&B Hoovers.
PAGE 1 SUN PHARMA GLOBAL FZE Directors’ Report The directors submit their report and accounts for the year ended 31 March 2017. Results and appropriations
Sun Pharma Global FZE company research & investing information. Find executives and the latest company news.
Sun Pharma Global FZE, c/o Sun Pharmaceutical Industries, Inc., 2 Independence Way, Princeton, NJ 08540. Therefore, approval of the applications listed in the table ...
Sun Pharma Global FZE drug, approved by USFDA DOXIL (doxorubicin HCl liposome injection) is doxorubicin hydrochloride (HCl) encapsulated in STEALTH® liposomes for intravenous administration.
Ilumya is a Trademark by Sun Pharma Global Fze, the address on file for this trademark is Saif Zone Executive Suite Y-43, P.O. Box 122304, Sharjah
Official Complaint for Patent Infringement in Civil Action No. 2:11-cv-06089-SRC-MAS: Janssen Pharmaceuticals, Inc. v. Sun Pharma Global Fze et. al. Filed in U.S. District Court for the District of New Jersey, the Hon. Stanley R. Chesler presiding.
View forest laboratories, llc et al v. sun pharma global fze et al: district of delaware various court filings, court venue of filed actions, upcoming trials or motions on calendar and post comments or questions.